Elwood Largis

1.2k total citations
30 papers, 977 citations indexed

About

Elwood Largis is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Elwood Largis has authored 30 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Physiology and 9 papers in Biochemistry. Recurrent topics in Elwood Largis's work include Adipose Tissue and Metabolism (13 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Effects and Assays (7 papers). Elwood Largis is often cited by papers focused on Adipose Tissue and Metabolism (13 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Effects and Assays (7 papers). Elwood Largis collaborates with scholars based in United States and Canada. Elwood Largis's co-authors include Minu Dutia, Jonathan D. Bloom, Michael Burns, Thomas H. Claus, Andrew S. Katocs, Allan Wissner, Donald O. Allen, James Ashmore, Stella Han and Frank D. Kolodgie and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Journal of Applied Physiology.

In The Last Decade

Elwood Largis

30 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elwood Largis United States 16 422 308 238 169 103 30 977
Laurie Tota United States 17 598 1.4× 245 0.8× 118 0.5× 339 2.0× 155 1.5× 25 1.1k
J. G. T. Sneyd New Zealand 10 576 1.4× 251 0.8× 183 0.8× 54 0.3× 24 0.2× 17 914
P. Dorigo Italy 16 333 0.8× 222 0.7× 108 0.5× 239 1.4× 30 0.3× 77 854
B. Middleton United Kingdom 21 764 1.8× 318 1.0× 145 0.6× 60 0.4× 19 0.2× 61 1.3k
Bharat Shimpukade Denmark 12 559 1.3× 186 0.6× 296 1.2× 132 0.8× 18 0.2× 15 962
Nancy J. Hutson United States 16 554 1.3× 316 1.0× 223 0.9× 48 0.3× 20 0.2× 18 1.2k
I.F. Skidmore United Kingdom 16 308 0.7× 341 1.1× 40 0.2× 94 0.6× 119 1.2× 37 870
Pasquale P. Vicario United States 19 855 2.0× 410 1.3× 167 0.7× 137 0.8× 8 0.1× 43 1.4k
William B. Benjamin United States 19 718 1.7× 344 1.1× 134 0.6× 15 0.1× 64 0.6× 29 1.1k
Peter Voß Germany 15 402 1.0× 237 0.8× 68 0.3× 150 0.9× 9 0.1× 25 986

Countries citing papers authored by Elwood Largis

Since Specialization
Citations

This map shows the geographic impact of Elwood Largis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elwood Largis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elwood Largis more than expected).

Fields of papers citing papers by Elwood Largis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elwood Largis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elwood Largis. The network helps show where Elwood Largis may publish in the future.

Co-authorship network of co-authors of Elwood Largis

This figure shows the co-authorship network connecting the top 25 collaborators of Elwood Largis. A scholar is included among the top collaborators of Elwood Largis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elwood Largis. Elwood Largis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sum, Fuk‐Wah, et al.. (2003). Cyclic amine sulfonamides as linkers in the design and synthesis of novel human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 13(13). 2191–2194. 18 indexed citations
2.
Steffan, Robert J., et al.. (2002). Novel substituted 4-aminomethylpiperidines as potent and selective human β3-agonists. Part 1: aryloxypropanolaminomethylpiperidines. Bioorganic & Medicinal Chemistry Letters. 12(20). 2957–2961. 8 indexed citations
3.
Steffan, Robert J., et al.. (2002). Novel substituted 4-aminomethylpiperidines as potent and selective human β3-agonists. Part 2: Arylethanolaminomethylpiperidines. Bioorganic & Medicinal Chemistry Letters. 12(20). 2963–2967. 8 indexed citations
4.
Hu, Baihua, et al.. (2001). New oxadiazolidinedione derivatives as potent and selective human β3 agonists. Bioorganic & Medicinal Chemistry Letters. 11(8). 981–984. 18 indexed citations
5.
Ashwell, Mark A., et al.. (2001). 4-Aminopiperidine ureas as potent selective agonists of the human β3-Adrenergic receptor. Bioorganic & Medicinal Chemistry Letters. 11(24). 3123–3127. 14 indexed citations
6.
Hu, Baihua, John W. Ellingboe, Iwan Gunawan, et al.. (2001). 2,4-thiazolidinediones as potent and selective human β3 agonists. Bioorganic & Medicinal Chemistry Letters. 11(6). 757–760. 31 indexed citations
7.
Hu, Baihua, John W. Ellingboe, Stella Han, et al.. (2001). Novel (4-Piperidin-1-yl)-phenyl Sulfonamides as Potent and Selective Human β3 Agonists. Bioorganic & Medicinal Chemistry. 9(8). 2045–2059. 36 indexed citations
8.
Gilbert, A., Aradhana M. Venkatesan, Gerardo D. Francisco, et al.. (1999). Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes. Bioorganic & Medicinal Chemistry Letters. 9(14). 1921–1926. 19 indexed citations
9.
Kolodgie, Frank D., Andrew S. Katocs, Elwood Largis, et al.. (1996). Hypercholesterolemia in the Rabbit Induced by Feeding Graded Amounts of Low-Level Cholesterol. Arteriosclerosis Thrombosis and Vascular Biology. 16(12). 1454–1464. 117 indexed citations
10.
Largis, Elwood, et al.. (1994). Antidiabetic and antiobesity effects of a highly selective β3‐adrenoceptor agonist (CL 316,243). Drug Development Research. 32(2). 69–76. 37 indexed citations
11.
Burns, Michael, Claire M. Fraser, A. Donny Strosberg, et al.. (1994). Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1000–1006. 72 indexed citations
12.
13.
Largis, Elwood, et al.. (1989). CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption.. Journal of Lipid Research. 30(5). 681–690. 116 indexed citations
14.
Bloom, Jonathan D., et al.. (1989). Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs. Journal of Medicinal Chemistry. 32(10). 2318–2325. 24 indexed citations
15.
Albright, J. Donald, et al.. (1983). Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben. Journal of Medicinal Chemistry. 26(10). 1378–1393. 15 indexed citations
16.
Allen, Donald O., Elwood Largis, & James Ashmore. (1974). Antilipolytic Action of Tolbutamide in Isolated Fat Cells of the Rat. Diabetes. 23(1). 51–54. 12 indexed citations
17.
Katocs, Andrew S., Elwood Largis, & Donald O. Allen. (1974). Role of Ca2+ in Adrenocorticotropic Hormone-stimulated Lipolysis in the Perifused Fat Cell System. Journal of Biological Chemistry. 249(7). 2000–2004. 16 indexed citations
18.
Allen, Donald O., Elwood Largis, Elizabeth A. Miller, & James Ashmore. (1973). Continuous monitoring of lipolytic rates in perifused isolated fat cells.. Journal of Applied Physiology. 34(1). 125–127. 31 indexed citations
19.
Largis, Elwood, et al.. (1973). Isoproterenol and glucagon effects in perfused hearts from spontaneously hypertensive and normotensive rats. Biochemical Pharmacology. 22(14). 1735–1744. 11 indexed citations
20.
Jacobs, Francis A. & Elwood Largis. (1969). Effect of Protein Inhibitors on Protein and Amino Acids in Mesenteric Lymph. Experimental Biology and Medicine. 130(3). 697–702. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurie Tota Breakdown of academic impact, for papers by J. G. T. Sneyd Breakdown of academic impact, for papers by P. Dorigo Breakdown of academic impact, for papers by B. Middleton Breakdown of academic impact, for papers by Bharat Shimpukade Breakdown of academic impact, for papers by Nancy J. Hutson Breakdown of academic impact, for papers by I.F. Skidmore Breakdown of academic impact, for papers by Pasquale P. Vicario Breakdown of academic impact, for papers by William B. Benjamin Breakdown of academic impact, for papers by Peter Voß
Rankless by CCL
2026